drugset

drugset / Trial / NCT02257970

Lymphedema Study for Arm or Leg Lymphedema

NCT02257970 ↗

Phase 4 Completed 117 enrolled Stanford University

RandomizedSequentialQuadruple-blindTreatment

Summary

This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.

Timeline

Start: 2009-03
Primary completion: 2016-12
Completion: 2017-03

Publications

Rockson SG, Tian W, Jiang X, Kuznetsova T, Haddad F, Zampell J, Mehrara B, Sampson JP, Roche L, Kim J, Nicolls MR. Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema. JCI Insight. 2018 Oct 18;3(20):e123775. doi: 10.1172/jci.insight.123775.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketoprofen	Small molecule	75 mg	Oral
Subject	Ketoprofen	Small molecule	225 mg	Oral
Subject	Ketoprofen	Small molecule	300 mg	Oral

Indications